Drug details:
Molecular formula: C₁₈H₁₉LiN₂O₃S

Standard name: lithium;(3R)-6-[(dimethylamino)methyl]-7-methyl-5-oxo-8-phenyl-2,3-dihydro-[1,3]thiazolo[3,2-a]pyridine-3-carboxylate

Curated SMILES: [Li+].CC1=C(C(=O)N2[C@H](CSC2=C1C3=CC=CC=C3)C(=O)[O-])CN(C)C

Evidence for compound's anti-virulence activity:

Escherichia
Related VF: Type 1 fimbriae; P fimbriae
Target: PapD
Drug effect: Blocking chaperone and usher functions.
Max phase: Preclinical (in vivo)
Publication:
Pinkner JS, et al., 2006. Rationally designed small compounds inhibit pilus biogenesis in uropathogenic bacteria. Proc Natl Acad Sci U S A 103(47):17897-902.